Corrigendum to 'Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial' [Vaccine 35 (2017) 395-402]

Autor:	Iro, MA, Snape, MD, Voysey, M, Jawad, S, Finn, A, Heath, PT, Bona, G, Esposito, S, Diez-Domingo, J, Prymula, R, Odueyungbo, A, Toneatto, D, Dull, P, Pollard, AJ, European Men B Vaccine Study Group
Jazyk:	angličtina
Rok vydání:	2017
Zdroj:	Vaccine. 35(24)
ISSN:	1873-2518 0264-410X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eec972447eba3e38330f9b9539ceaae7 http://ora.ox.ac.uk/objects/uuid: Zobrazit plný text záznamu Full Text from ScienceDirect